In human disease, patients with DCM, coding polymorphisms of TLR4 were associated with significantly reduced improvement of left ventricular ejection fraction and left ventricular dilation at the follow-up evaluation when compared with carriers of the wild type gene under the same treatment conditions [48]. This evidence concerns the gene TLR4 and familial dilated cardiomyopathy.